Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions [Yahoo! Finance]
MeiraGTx Holdings plc - Ordinary Shares (MGTX)
Company Research
Source: Yahoo! Finance
TheFly reported on April 1 that Evercore ISI analyst Gavin Clark-Gartner reduced the price target on MGTX from $20 to $18 while maintaining an Outperform rating. The revision was part of a broader update across small- and mid-cap biotechnology companies tied to an assessment of upcoming second-quarter catalysts. The firm also considered longer-term developments, noting that stock performance in the sector is increasingly influenced by expectations around full-year 2026 milestones. Earlier on March 26, MeiraGTx Holdings plc (NASDAQ:MGTX) announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to its AAV2-hAQP1 program for treating Grade 2 and Grade 3 late xerostomia resulting from radiotherapy in cancers of the upper aerodigestive tract. Evercore Maintains Positive Stance on MeiraGTx Holdings plc (MGTX) Amid Sector Revisions The designation was supported by long-term data from a Phase 1 dose-escalation study demonstrating sustained outcomes.
Show less
Read more
Impact Snapshot
Event Time:
MGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTX alerts
High impacting MeiraGTx Holdings plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MGTX
News
- MeiraGTx (MGTX) had its price target raised by Royal Bank Of Canada from $16.00 to $24.00. They now have an "outperform" rating on the stock.MarketBeat
- MeiraGTx Announces Pricing of $100 Million Offering of Ordinary SharesGlobeNewswire
- MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced XerostomiaGlobeNewswire
- MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026GlobeNewswire
- MeiraGTx (MGTX) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MGTX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" to "hold"MarketBeat
MGTX
Earnings
- 3/26/26 - Miss
MGTX
Sec Filings
- 4/16/26 - Form 424B5
- 4/16/26 - Form 8-K
- 4/16/26 - Form 8-K
- MGTX's page on the SEC website